Ampio Pharmaceuticals Inc.
AMPE
AMPE was delisted on the 12th of April, 2024.
71 hedge funds and large institutions have $12.8M invested in Ampio Pharmaceuticals Inc. in 2016 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 18 increasing their positions, 17 reducing their positions, and 9 closing their positions.
44% more capital invested
Capital invested by funds: $8.86M → $12.8M (+$3.92M)
16% more call options, than puts
Call options by funds: $123K | Put options by funds: $106K
6% more repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 17
0% more funds holding
Funds holding: 71 → 71 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.89M |
| 2 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$290K |
| 3 |
Morgan Stanley
New York
|
+$106K |
| 4 |
VKH
Virtu KCG Holdings
New York
|
+$61.9K |
| 5 |
Group One Trading
Chicago,
Illinois
|
+$45.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NFG
Noven Financial Group
Denver,
Colorado
|
-$202K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$166K |
| 3 |
Renaissance Technologies
New York
|
-$128K |
| 4 |
SG Americas Securities
New York
|
-$60K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$51.2K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
76
Goldman Sachs
New York
| – | -$9K | -42 | Closed |
|
|
SB
77
Suntrust Banks
Atlanta,
Georgia
| – | -$34K | -36 | Closed |
|
78
Principal Financial Group
Des Moines,
Iowa
| – | -$7K | -33 | Closed |
|
|
IA
79
IFP Advisors
Tampa,
Florida
| – | -$2K | -11 | Closed |
|
AMPE Hedge Fund Activity: Q4 2016 in Review
71 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Ampio Pharmaceuticals Inc. (AMPE) for Q4 2016, worth a combined $12.8M — up 44% from $8.86M a quarter earlier.
Fund positioning in AMPE was balanced in Q4 2016: 9 funds opened new positions, 9 closed out, 18 added to existing stakes and 17 trimmed.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $1.89M. The largest seller was Noven Financial Group, cutting an estimated $202K.
- 71 institutional investors held Ampio Pharmaceuticals Inc. (AMPE) as of Q4 2016, unchanged from Q3 2016.
- Funds reported $12.8M of Ampio Pharmaceuticals Inc. stock for Q4 2016, up 44% quarter-over-quarter.
- 9 funds opened new Ampio Pharmaceuticals Inc. positions in Q4 2016 and 9 closed out, a net change of 0 holders.
- The largest Ampio Pharmaceuticals Inc. buyer in Q4 2016 was Susquehanna International Group, an estimated $1.89M added.
- The largest Ampio Pharmaceuticals Inc. seller in Q4 2016 was Noven Financial Group, an estimated $202K sold.
Based on aggregated 13F filings for Q4 2016.